1-4 of 4
off-label use
Close
Sort by
Journal Articles

Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting

Aaron C. Logan, Lawrence T. Goodnough
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 153–159.
https://doi.org/10.1182/asheducation-2010.1.153
Published: 2010
Journal Articles

What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?

Rachel P. Rosovsky, Mark A. Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 36–38.
https://doi.org/10.1182/asheducation-2008.1.36
Published: 2008
Journal Articles

Challenges in the Therapeutic Use of a “So-Called” Universal Hemostatic Agent: Recombinant Factor VIIa

W. Keith Hoots
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 426–431.
https://doi.org/10.1182/asheducation-2006.1.426
Published: 2006
Journal Articles

New Perspectives in Hemophilia Treatment

Craig M. Kessler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 429–435.
https://doi.org/10.1182/asheducation-2005.1.429
Published: 2005